Anavex Life Sciences AVXL
NASDAQ AVXL
$1.33 -0.03 (-2.21%)
At close: Oct 23, 2026 · 4:00 PM EDT

Anavex Life Sciences (AVXL) Net Debt Issuances and Repayments (2010 - 2014)

Updated

Analysis

Anavex Life Sciences (AVXL) Net Debt Issuances and Repayments (2010 - 2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 11.58 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -4.36 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -2.00 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -5.00 Mn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 2.17 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -2.46 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -17.00 Mn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 64.00 Mn
10 Anavex Life Sciences 121.90 Mn -358.18 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 -88,144.00
Mar 31, 2014 10.00 Mn
Mar 31, 2013 50,000.00
Dec 31, 2012 200,000.00
Sep 30, 2012 250,000.00
Jun 30, 2012 81,500.00
Dec 31, 2011 250,000.00
Jun 30, 2011 750,000.00
Sep 30, 2010 40,000.00
API Access

Anavex Life Sciences Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=AVXL&period=max&api_key=YOUR_API_KEY